Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 36B pseudogene 2 (ANKRD36BP2) is a human pseudogene located on chromosome 2 and annotated under NCBI Gene ID 645784[11]. Pseudogenes like ANKRD36BP2 are genomic sequences similar to known genes but are generally considered non-functional due to mutations that prevent the production of a functional protein[7][9]. Although traditionally labeled as "junk DNA," pseudogenes may have regulatory functions through their RNA transcripts, which can modulate gene expression of parental or other genes by acting as miRNA sponges or producing regulatory RNAs[7][9]. ANKRD36BP2 has known expression profiles in various tissues, but does not encode a protein with established function[3][1]. There are no known drugs, diagnostic biomarkers, or clinically validated mechanisms of action for this locus. Some large-scale bioinformatics analyses suggest the pseudogene might be associated with disease states (e.g., gastric cancer[3]), but these findings are preliminary and not sufficient to define it as a therapeutic target. Summary: ANKRD36BP2 is a pseudogene, not a therapeutic target, with no known protein product, drug interactions, or established clinical functions. While its transcripts may have regulatory potential (as is generally true for some pseudogenes), there is not enough evidence to support its inclusion as a canonical molecular target in a therapeutic or biomarker context[3][7][9][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 36B pseudogene 2 (ANKRD36BP2).